Stocks
Intra-Cellular Therapies (ITCI) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -75.8% | -34.6% | -68.0% | -39.1% | -23.6% | -18.5% | ||
| Changes by years, y/y, % | -27pp | +41pp | -33pp | +29pp | +15pp | -13.5% | |||
Intra-Cellular Therapies. ROE, %
Intra-Cellular Therapies. ROE, changes, pp
Intra-Cellular Therapies (ITCI) ROE US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| ROE, % | ? | -34.9% | -29.3% | -24.7% | -23.6% | -18.5% | -18.5% | |
| Changes by years, y/y, % | +3pp | +15pp | +18pp | +14pp | +16pp | |||
| Changes by quarters, q/q, % | +3pp | +6pp | +5pp | +1pp | +5pp | |||
